NEXGEL GAAP EPS of -$0.08, revenue of $2.93M
Source: SeekingAlpha
2025-11-11 17:13:48 ET
More on NEXGEL
- Seeking Alpha’s Quant Rating on NEXGEL
- Historical earnings data for NEXGEL
- Financial information for NEXGEL
Read the full article on Seeking Alpha
For further details see:
NEXGEL GAAP EPS of -$0.08, revenue of $2.93M
NexGel Inc
NASDAQ: NXGL
NXGL Trading
-9.82% G/L:
$0.7731 Last:
283,946 Volume:
$0.84 Open:
NXGL Latest News
March 12, 2026 08:45:00 am
NEXGEL Announces Consideration Terms of Agreement to License and Acquire Portfolio of Commercial-Stage Regenerative Biomaterial Products
March 12, 2026 08:30:00 am
Celularity Reiterates Strategic Commercialization Partnership with NEXGEL Focused on Building Biomaterials Franchise with Established Commercial Products and New 510(k) Pathway Product Opportunities
NXGL Stock Data
$10,748,936
6,469,719
5.78%
9
N/A
Medical Equipment & Supplies
Healthcare
US
Langhorne
